Natera partners with Angiex for ctDNA monitoring in solid tumor trial
Natera partnered with Angiex to support ctDNA monitoring in a solid tumor trial using Signatera.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.